LabCompass

Matthew E. Long

Medicine · The Ohio State University

Mid career · publishing since 2010

Publications

39

Citations

1,212

Est. group size

~2

Recurring co-author estimate

Active years

16

Publishing since 2010

Research summary
AI-generated

Matthew E. Long's research focuses on how immune cells, particularly macrophages, drive inflammation in chronic lung diseases such as cystic fibrosis, COPD, and bacterial lung infections. A recurring theme is targeting cell-signaling pathways (like MEK1/2) and testing drugs (such as CFTR modulators and gallium compounds) to reduce harmful inflammation while preserving the body's ability to fight infection. Work also extends to broader topics including gene editing safety and genetic risk factors in other diseases.

Macrophage biology and inflammationCystic fibrosis and airway diseaseMEK1/2 signaling pathway inhibitionChronic lung disease (COPD, pneumonia)Immune response to bacterial infection

Publication output has been relatively steady with some fluctuation, averaging about 3 papers per year over the last five years, with recent upticks in 2024 and 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.0/year recently
2017: 2 publications172018: 2 publications182019: 1 publication192020: 5 publications5202021: 3 publications212022: 5 publications5222023: 1 publication232024: 4 publications242025: 5 publications52526
Recent publications
Publishes in
  • Journal of Cystic Fibrosis×3
  • Molecular Therapy×2
  • JCI Insight×2
  • bioRxiv (Cold Spring Harbor Laboratory)×2
  • Clinical Science×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile